Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Influence of Cellular, Microenvironmental, and Growth Parameters on Thermotolerance Kinetics in Vivo in Human Melanoma Xenografts

Einar K. Rofstad
Einar K. Rofstad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 1989
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The kinetics of thermotolerance in five human melanoma xenograft lines grown in BALB/c-nu/nu/BOM mice was studied in vivo. Local hyperthermia was given by immersing the tumor-bearing leg of the mice into a thermostatically regulated water bath. Specific growth delay was used as the end point for tumor response. Thermotolerance ratio (TTR), i.e., the ratio of the slopes of dose-response curves (specific growth delay versus heating time) for single-heated and preheated tumors, was used as a quantitative measure of thermotolerance. All melanoma lines developed thermotolerance; TTR reached a maximum (TTRmax) 16 to 24 h after the conditioning heat treatment and then decayed slowly. TTRmax and the time necessary to reach TTRmax tended to increase with increasing conditioning heat dose, whereas the half-time of thermotolerance decay did not change with the conditioning heat dose. The kinetics of thermotolerance differed considerably among the melanoma lines. After a conditioning heat treatment of 43.5°C for 30 min, TTRmax ranged from 2.3 ± 0.5 to 7.0 ± 1.2, the half-time of thermotolerance decay from 53 ± 13 h to 142 ± 30 h and the time necessary to reach complete decay of the thermotolerance from 5 days to more than 14 days. TTRmax showed no correlation to heat sensitivity or any known growth and microenvironmental parameter of the melanoma lines. On the other hand, TTRmax was positively correlated to TTRmax measured in vitro when cells from the melanomas were studied in soft agar. However, TTRmax in vivo was always somewhat lower than TTRmax in vitro. Consequently, the development of thermotolerance in the melanomas in vivo was governed mainly by the intrinsic ability of the tumor cells to develop thermotolerance and was just slightly modified by the tumor microenvironment. The rate of thermotolerance decay was independent of TTRmax. The half-times of thermotolerance decay in vivo were longer than, and not correlated to, those measured in vitro. However, the decay half-time in vivo tended to increase with increasing tumor volume-doubling time, and to decrease with increasing growth fraction and vascular density. There was no relationship between decay half-time and fraction of radiobiologically hypoxic cells. Consequently, the rate of thermotolerance decay in the melanomas in vivo was governed mainly by tumor growth parameters and not by intrinsic characteristics of the tumor cells. The considerable difference in the kinetics of thermotolerance observed among the melanoma lines suggests that fractionated hyperthermia cannot be expected to give optimum clinical results until individualized treatment regimens are being used. Thus, a simple and accurate predictive assay for thermotolerance is highly warranted. Intrinsic characteristics of the tumor cells as well as tumor growth properties have to be taken into consideration in the development of such predictive assays. The present results indicate that clinical treatment protocols probably should not prescribe more than one hyperthermic treatment per week.

Footnotes

  • ↵1 Support was received from The Norwegian Cancer Society, The Norwegian Research Council for Science and the Humanities, and The Nansen Scientific Fund.

  • ↵2 To whom requests for reprints should be addressed, at Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo 3, Norway.

  • Received January 6, 1989.
  • Revision received May 15, 1989.
  • Accepted June 20, 1989.
  • ©1989 American Association for Cancer Research.
PreviousNext
Back to top
September 1989
Volume 49, Issue 18
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Influence of Cellular, Microenvironmental, and Growth Parameters on Thermotolerance Kinetics in Vivo in Human Melanoma Xenografts
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Influence of Cellular, Microenvironmental, and Growth Parameters on Thermotolerance Kinetics in Vivo in Human Melanoma Xenografts
Einar K. Rofstad
Cancer Res September 15 1989 (49) (18) 5027-5032;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Influence of Cellular, Microenvironmental, and Growth Parameters on Thermotolerance Kinetics in Vivo in Human Melanoma Xenografts
Einar K. Rofstad
Cancer Res September 15 1989 (49) (18) 5027-5032;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Laminin Receptor Complementary DNA-deduced Synthetic Peptide Inhibits Cancer Cell Attachment to Endothelium
  • T-Cell Receptor Vβ Gene Expression Differs in Tumor-infiltrating Lymphocytes within Primary and Metastatic Melanoma
  • Acidic and Basic Fibrolast Growth Factors Are Present in Glioblastoma Multiforme
Show more Basic Sciences

Articles

  • Laminin Receptor Complementary DNA-deduced Synthetic Peptide Inhibits Cancer Cell Attachment to Endothelium
  • T-Cell Receptor Vβ Gene Expression Differs in Tumor-infiltrating Lymphocytes within Primary and Metastatic Melanoma
  • Acidic and Basic Fibrolast Growth Factors Are Present in Glioblastoma Multiforme
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement